FDA approves new indication for drug to treat severe COVID-19

The FDA on May 11 approved Eli Lilly and partner Incyte's baricitinib, which goes by the brand name Olumiant, to treat COVID-19 in certain hospitalized adults. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive